nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.482	1	CbGbCtD
Etodolac—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0251	0.184	CbGpPWpGaD
Etodolac—Cutaneous vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0598	CcSEcCtD
Etodolac—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0546	CcSEcCtD
Etodolac—UGT1A10—renal system—nephrolithiasis	0.0129	0.135	CbGeAlD
Etodolac—UGT1A10—kidney—nephrolithiasis	0.0124	0.13	CbGeAlD
Etodolac—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0117	0.0855	CbGpPWpGaD
Etodolac—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0116	0.0846	CbGpPWpGaD
Etodolac—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.00924	0.0323	CcSEcCtD
Etodolac—RXRA—Vitamin D Metabolism—PTH—nephrolithiasis	0.009	0.0659	CbGpPWpGaD
Etodolac—PTGS2—nephron—nephrolithiasis	0.00827	0.0866	CbGeAlD
Etodolac—RXRA—renal system—nephrolithiasis	0.00767	0.0803	CbGeAlD
Etodolac—CYP2C9—urine—nephrolithiasis	0.0076	0.0796	CbGeAlD
Etodolac—RXRA—kidney—nephrolithiasis	0.00741	0.0777	CbGeAlD
Etodolac—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0233	CcSEcCtD
Etodolac—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00662	0.0231	CcSEcCtD
Etodolac—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00649	0.0227	CcSEcCtD
Etodolac—UGT1A9—renal system—nephrolithiasis	0.00645	0.0676	CbGeAlD
Etodolac—UGT1A9—kidney—nephrolithiasis	0.00624	0.0654	CbGeAlD
Etodolac—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00583	0.0204	CcSEcCtD
Etodolac—SLC22A6—nephron tubule—nephrolithiasis	0.00525	0.0551	CbGeAlD
Etodolac—UGT2B7—renal system—nephrolithiasis	0.0052	0.0545	CbGeAlD
Etodolac—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00509	0.0178	CcSEcCtD
Etodolac—UGT2B7—kidney—nephrolithiasis	0.00503	0.0527	CbGeAlD
Etodolac—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00461	0.0338	CbGpPWpGaD
Etodolac—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00458	0.016	CcSEcCtD
Etodolac—SLC22A6—cortex of kidney—nephrolithiasis	0.0045	0.0471	CbGeAlD
Etodolac—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00422	0.0147	CcSEcCtD
Etodolac—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00419	0.0147	CcSEcCtD
Etodolac—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00408	0.0143	CcSEcCtD
Etodolac—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00404	0.0141	CcSEcCtD
Etodolac—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00404	0.0141	CcSEcCtD
Etodolac—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0129	CcSEcCtD
Etodolac—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0129	CcSEcCtD
Etodolac—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00363	0.0127	CcSEcCtD
Etodolac—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00359	0.0125	CcSEcCtD
Etodolac—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00344	0.012	CcSEcCtD
Etodolac—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00342	0.012	CcSEcCtD
Etodolac—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00341	0.0119	CcSEcCtD
Etodolac—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00341	0.0119	CcSEcCtD
Etodolac—UGT1A3—Phase II conjugation—SLC26A1—nephrolithiasis	0.00338	0.0247	CbGpPWpGaD
Etodolac—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0118	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0113	CcSEcCtD
Etodolac—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00296	0.0103	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00292	0.0102	CcSEcCtD
Etodolac—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00287	0.021	CbGpPWpGaD
Etodolac—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00287	0.01	CcSEcCtD
Etodolac—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00986	CcSEcCtD
Etodolac—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00275	0.0096	CcSEcCtD
Etodolac—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00916	CcSEcCtD
Etodolac—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00916	CcSEcCtD
Etodolac—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00904	CcSEcCtD
Etodolac—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00894	CcSEcCtD
Etodolac—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00883	CcSEcCtD
Etodolac—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00878	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00865	CcSEcCtD
Etodolac—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00861	CcSEcCtD
Etodolac—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00858	CcSEcCtD
Etodolac—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00856	CcSEcCtD
Etodolac—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00851	CcSEcCtD
Etodolac—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00849	CcSEcCtD
Etodolac—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00837	CcSEcCtD
Etodolac—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00832	CcSEcCtD
Etodolac—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00819	CcSEcCtD
Etodolac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00234	0.0171	CbGpPWpGaD
Etodolac—UGT1A9—Phase II conjugation—SLC26A1—nephrolithiasis	0.00234	0.0171	CbGpPWpGaD
Etodolac—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00815	CcSEcCtD
Etodolac—UGT1A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00225	0.0165	CbGpPWpGaD
Etodolac—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00786	CcSEcCtD
Etodolac—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00224	0.00784	CcSEcCtD
Etodolac—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00778	CcSEcCtD
Etodolac—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00218	0.0159	CbGpPWpGaD
Etodolac—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00755	CcSEcCtD
Etodolac—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00741	CcSEcCtD
Etodolac—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00731	CcSEcCtD
Etodolac—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00727	CcSEcCtD
Etodolac—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.002	0.007	CcSEcCtD
Etodolac—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00693	CcSEcCtD
Etodolac—UGT1A3—Biological oxidations—SLC26A1—nephrolithiasis	0.00198	0.0145	CbGpPWpGaD
Etodolac—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00672	CcSEcCtD
Etodolac—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00192	0.014	CbGpPWpGaD
Etodolac—Tension—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00669	CcSEcCtD
Etodolac—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00668	CcSEcCtD
Etodolac—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00663	CcSEcCtD
Etodolac—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00643	CcSEcCtD
Etodolac—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00639	CcSEcCtD
Etodolac—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00633	CcSEcCtD
Etodolac—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00631	CcSEcCtD
Etodolac—RXRA—NRF2 pathway—SLC2A9—nephrolithiasis	0.00179	0.0131	CbGpPWpGaD
Etodolac—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00623	CcSEcCtD
Etodolac—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00176	0.00615	CcSEcCtD
Etodolac—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00613	CcSEcCtD
Etodolac—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00612	CcSEcCtD
Etodolac—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00611	CcSEcCtD
Etodolac—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00603	CcSEcCtD
Etodolac—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00172	0.006	CcSEcCtD
Etodolac—PTGS1—renal system—nephrolithiasis	0.0017	0.0178	CbGeAlD
Etodolac—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00168	0.0123	CbGpPWpGaD
Etodolac—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00581	CcSEcCtD
Etodolac—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00581	CcSEcCtD
Etodolac—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00579	CcSEcCtD
Etodolac—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00574	CcSEcCtD
Etodolac—PTGS1—kidney—nephrolithiasis	0.00164	0.0172	CbGeAlD
Etodolac—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00568	CcSEcCtD
Etodolac—PTGS2—renal system—nephrolithiasis	0.00162	0.017	CbGeAlD
Etodolac—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00561	CcSEcCtD
Etodolac—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00557	CcSEcCtD
Etodolac—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00557	CcSEcCtD
Etodolac—RXRA—Biological oxidations—SLC26A1—nephrolithiasis	0.00157	0.0115	CbGpPWpGaD
Etodolac—Shock—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00548	CcSEcCtD
Etodolac—PTGS2—kidney—nephrolithiasis	0.00157	0.0164	CbGeAlD
Etodolac—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00545	CcSEcCtD
Etodolac—UGT1A9—NRF2 pathway—SLC2A9—nephrolithiasis	0.00156	0.0114	CbGpPWpGaD
Etodolac—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00543	CcSEcCtD
Etodolac—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00538	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00153	0.0112	CbGpPWpGaD
Etodolac—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00531	CcSEcCtD
Etodolac—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00149	0.0052	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00507	CcSEcCtD
Etodolac—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00504	CcSEcCtD
Etodolac—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00143	0.005	CcSEcCtD
Etodolac—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00142	0.00496	CcSEcCtD
Etodolac—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00142	0.00495	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0014	0.0103	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0014	0.0103	CbGpPWpGaD
Etodolac—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0049	CcSEcCtD
Etodolac—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00484	CcSEcCtD
Etodolac—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0048	CcSEcCtD
Etodolac—UGT1A9—Biological oxidations—SLC26A1—nephrolithiasis	0.00137	0.01	CbGpPWpGaD
Etodolac—Pain—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00476	CcSEcCtD
Etodolac—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00476	CcSEcCtD
Etodolac—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00131	0.00459	CcSEcCtD
Etodolac—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0013	0.00455	CcSEcCtD
Etodolac—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00442	CcSEcCtD
Etodolac—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0044	CcSEcCtD
Etodolac—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0044	CcSEcCtD
Etodolac—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00117	0.0041	CcSEcCtD
Etodolac—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00399	CcSEcCtD
Etodolac—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00394	CcSEcCtD
Etodolac—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00111	0.00815	CbGpPWpGaD
Etodolac—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00381	CcSEcCtD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00106	0.00779	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00106	0.00779	CbGpPWpGaD
Etodolac—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00368	CcSEcCtD
Etodolac—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00101	0.00354	CcSEcCtD
Etodolac—Rash—Hydrochlorothiazide—nephrolithiasis	0.00101	0.00351	CcSEcCtD
Etodolac—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.001	0.00351	CcSEcCtD
Etodolac—Headache—Hydrochlorothiazide—nephrolithiasis	0.000999	0.00349	CcSEcCtD
Etodolac—RXRA—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000997	0.0073	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000997	0.0073	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000989	0.00724	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000989	0.00724	CbGpPWpGaD
Etodolac—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000947	0.00331	CcSEcCtD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000889	0.00651	CbGpPWpGaD
Etodolac—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000881	0.00645	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000875	0.0064	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000875	0.0064	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000852	0.00623	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000813	0.00595	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000813	0.00595	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000798	0.00584	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00078	0.00571	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00073	0.00534	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00073	0.00534	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000713	0.00522	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000713	0.00522	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000616	0.00451	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000616	0.00451	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000586	0.00429	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000573	0.00419	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000573	0.00419	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000553	0.00405	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000553	0.00405	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00054	0.00396	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00054	0.00396	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000522	0.00382	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000514	0.00376	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000514	0.00376	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00051	0.00374	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00051	0.00374	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000502	0.00368	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000502	0.00368	CbGpPWpGaD
Etodolac—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000458	0.00335	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000455	0.00333	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000455	0.00333	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000448	0.00328	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000448	0.00328	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GRHPR—nephrolithiasis	0.000446	0.00327	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000408	0.00299	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000405	0.00297	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AGXT—nephrolithiasis	0.000398	0.00291	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.000379	0.00278	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000371	0.00271	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000371	0.00271	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000358	0.00262	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GRHPR—nephrolithiasis	0.000354	0.00259	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.000338	0.00248	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—APRT—nephrolithiasis	0.000338	0.00248	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—SLC26A1—nephrolithiasis	0.000338	0.00248	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AGXT—nephrolithiasis	0.000315	0.00231	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GRHPR—nephrolithiasis	0.000308	0.00226	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000288	0.0021	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000288	0.0021	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000281	0.00206	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000281	0.00206	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AGXT—nephrolithiasis	0.000275	0.00201	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000269	0.00197	CbGpPWpGaD
Etodolac—ALB—Hemostasis—DGKH—nephrolithiasis	0.000269	0.00197	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APRT—nephrolithiasis	0.000268	0.00196	CbGpPWpGaD
Etodolac—RXRA—Metabolism—SLC26A1—nephrolithiasis	0.000268	0.00196	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000261	0.00191	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000261	0.00191	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000251	0.00184	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AQP1—nephrolithiasis	0.000241	0.00176	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APRT—nephrolithiasis	0.000234	0.00171	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC26A1—nephrolithiasis	0.000234	0.00171	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000233	0.0017	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000233	0.0017	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000224	0.00164	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CHRM3—nephrolithiasis	0.000218	0.0016	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000205	0.0015	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GRHPR—nephrolithiasis	0.0002	0.00146	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AQP1—nephrolithiasis	0.000191	0.0014	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APRT—nephrolithiasis	0.00019	0.00139	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.00019	0.00139	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000186	0.00136	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000185	0.00136	CbGpPWpGaD
Etodolac—PTGS2—Disease—SLC26A1—nephrolithiasis	0.000181	0.00132	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AGXT—nephrolithiasis	0.000178	0.0013	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CHRM3—nephrolithiasis	0.000173	0.00127	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AQP1—nephrolithiasis	0.000166	0.00122	CbGpPWpGaD
Etodolac—ALB—Metabolism—GRHPR—nephrolithiasis	0.000161	0.00118	CbGpPWpGaD
Etodolac—PTGS2—Disease—ATP6V0A4—nephrolithiasis	0.000161	0.00118	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APRT—nephrolithiasis	0.000151	0.00111	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC26A1—nephrolithiasis	0.000151	0.00111	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CHRM3—nephrolithiasis	0.000151	0.0011	CbGpPWpGaD
Etodolac—ALB—Metabolism—AGXT—nephrolithiasis	0.000144	0.00105	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000136	0.000994	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000132	0.000967	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000123	0.000898	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000122	0.000896	CbGpPWpGaD
Etodolac—ALB—Metabolism—APRT—nephrolithiasis	0.000122	0.000896	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000118	0.000862	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AQP1—nephrolithiasis	0.000108	0.000789	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APRT—nephrolithiasis	0.0001	0.000733	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.0001	0.000733	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CHRM3—nephrolithiasis	9.74e-05	0.000713	CbGpPWpGaD
Etodolac—ALB—Metabolism—AQP1—nephrolithiasis	8.72e-05	0.000638	CbGpPWpGaD
Etodolac—ALB—Metabolism—CHRM3—nephrolithiasis	7.88e-05	0.000577	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AQP1—nephrolithiasis	7.13e-05	0.000522	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CHRM3—nephrolithiasis	6.45e-05	0.000472	CbGpPWpGaD
